OFF-BRAND STI571: A BUDGET-FRIENDLY ALTERNATIVE?

The emergence of off-brand imatinib represents a significant possibility for patients battling CML and other illnesses. Original brand-name imatinib, often referred to as Gleevec, carries a steep price cost, frequently presenting a challenge for accessibility for some individuals. Common versions